Showing results (721-730 of 873) with videos related to

Sort By:
Pageof 88
Cancers|September 24, 2020
Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC TreatmentJudy R van Beijnum, Andrea Weiss, Robert H Berndsen, et al.
European Journal of Medicinal Chemistry|December 3, 2014
Novel analogs of antitumor agent calixarene 0118: Synthesis, cytotoxicity, click labeling with 2-[(18)F]fluoroethylazide, and in vivo evaluationTilman Läppchen, Ruud P M Dings, Raffaella Rossin, et al.
Alzheimer'S Research & Therapy|April 8, 2024
Use of a digital tool to support the diagnostic process in memory clinics-a usability studyAniek M van Gils, Hanneke F M Rhodius-Meester, Dédé Handgraaf, et al.
Cancer Research|November 11, 2010
High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanningCornelis A M Van Bergen, Caroline E Rutten, Edith D Van Der Meijden, et al.
Iscience|February 8, 2021
Healthy cells functionally present TAP-independent SSR1 peptides: implications for selection of clinically relevant antigensAntonius A de Waard, Tamara Verkerk, Kelly Hoefakker, et al.
Oncoimmunology|June 5, 2013
Functional characterization of a STAT3-dependent dendritic cell-derived CD14<sup>+</sup> cell population arising upon IL-10-driven maturationJelle J Lindenberg, Rieneke van de Ven, Sinéad M Lougheed, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 25, 2002
The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal modelsDaisy W J van der Schaft, Ruud P M Dings, Quido G de Lussanet, et al.
American Journal of Hematology|October 30, 2018
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expressionFloris C Loeff, Kevin Rijs, Esther H M van Egmond, et al.
Frontiers in Immunology|January 9, 2019
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class IIPeter van Balen, Cornelis A M van Bergen, Simone A P van Luxemburg-Heijs, et al.
Breast (Edinburgh, Scotland)|July 6, 2024
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCISE G Engelhardt, R S J M Schmitz, M A Gerritsma, et al.
Pageof 88